Effect of hormonal therapy on the otoconial changes caused by … – Nature.com

von Brevern, M. et al. Epidemiology of benign paroxysmal positional vertigo: A population based study. J. Neurol. Neurosurg. Psychiatry 78, 710715 (2007).

Article Google Scholar

Imai, T. et al. Natural course of the remission of vertigo in patients with benign paroxysmal positional vertigo. Neurology 64, 920921 (2005).

Article CAS Google Scholar

Salvinelli, F. et al. Treatment of benign positional vertigo in the elderly: A randomized trial. Laryngoscope 114, 827831 (2004).

Article Google Scholar

Nunez, R. A., Cass, S. P. & Furman, J. M. Short- and long-term outcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol. Head Neck Surg. 122, 647652 (2000).

Article CAS Google Scholar

Yang, C. J., Kim, Y., Lee, H. S. & Park, H. J. Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo. J. Vestib. Res. 27, 287294 (2018).

Article Google Scholar

Kim, S. Y., Han, S. H., Kim, Y. H. & Park, M. H. Clinical features of recurrence and osteoporotic changes in benign paroxysmal positional vertigo. Auris Nasus Larynx 44, 156161 (2017).

Article Google Scholar

Brandt, T., Huppert, D., Hecht, J., Karch, C. & Strupp, M. Benign paroxysmal positioning vertigo: A long-term follow-up (617 years) of 125 patients. Acta Otolaryngol. 126, 160163 (2006).

Article Google Scholar

Gmiz, M. J. & Lopez-Escamez, J. A. Health-related quality of life in patients over sixty years old with benign paroxysmal positional vertigo. Gerontology 50, 8286 (2004).

Article Google Scholar

Ogun, O. A., Bki, B., Cohn, E. S., Janky, K. L. & Lundberg, Y. W. Menopause and benign paroxysmal positional vertigo. Menopause 21, 886889 (2014).

Article Google Scholar

Liu, D. H. et al. Age-related increases in benign paroxysmal positional vertigo are reversed in women taking estrogen replacement therapy: A population-based study in Taiwan. Front. Aging Neurosci. 9, 404 (2017).

Article Google Scholar

Karata, A. et al. Association of benign paroxysmal positional vertigo with osteoporosis and vitamin D deficiency: A case controlled study. J. Int. Adv. Otol. 13, 259265 (2017).

Article Google Scholar

Talaat, H. S., Abuhadied, G., Talaat, A. S. & Abdelaal, M. S. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur. Arch. Otorhinolaryngol. 272, 22492253 (2015).

Article Google Scholar

Wang, Z. et al. Evaluation of bone mineral density and 25-(OH) vitamin D levels in middle-aged and elderly women with recurrent benign paroxysmal positional vertigo. Acta Otolaryngol. 140, 8993 (2020).

Article CAS Google Scholar

Lee, S. B., Lee, C. H., Kim, Y. J. & Kim, H. M. Biochemical markers of bone turnover in benign paroxysmal positional vertigo. PLoS ONE 12, e0176011 (2017).

Article Google Scholar

Ding, J., Liu, L., Kong, W. K., Chen, X. B. & Liu, X. Serum levels of 25-hydroxy vitamin D correlate with idiopathic benign paroxysmal positional vertigo. Biosci. Rep. 39, BSR20190142 (2019).

Jeong, S. H. et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J. Neurol. 260, 832838 (2013).

Article CAS Google Scholar

Rhim, G. I. Serum vitamin D and recurrent benign paroxysmal positional vertigo. Laryngoscope Investig. Otolaryngol. 1, 150153 (2016).

Article Google Scholar

Yang, L. et al. Mechanism underlying the effects of estrogen deficiency on otoconia. J. Assoc. Res. Otolaryngol. 19, 353362 (2018).

Article Google Scholar

Vibert, D. et al. Ultrastructural changes in otoconia of osteoporotic rats. Audiol. Neurootol. 13, 293301 (2008).

Article Google Scholar

Nishihara, E. et al. Evaluation of the structure of the otoconial layer using micro-computed tomography. Auris Nasus Larynx 47, 734739 (2020).

Article Google Scholar

Prokai, L. et al. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl Acad. Sci. U. S. A. 100, 1174111746 (2003).

Article ADS CAS Google Scholar

ahin, E. et al. Oxidative status in patients with benign paroxysmal positional vertigo. J. Int. Adv. Otol. 14, 299303 (2018).

Article Google Scholar

Gltrk, M. T., nal, Z. N., smi, O., imen, M. B. & nal, M. The role of oxidative stress and inflammatory mediators in benign paroxysmal positional vertigo. J. Int. Adv. Otol. 12, 101105 (2016).

Article Google Scholar

Goto, F., Hayashi, K., Kunihiro, T. & Ogawa, K. The possible contribution of angiitis to the onset of benign paroxysmal positional vertigo (BPPV). Int. Tinnitus J. 16, 2528 (2010).

Google Scholar

Cui, J., Shen, Y. & Li, R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol. Med. 19, 197209 (2013).

Article CAS Google Scholar

Palacios, S., Stevenson, J. C., Schaudig, K., Lukasiewicz, M. & Graziottin, A. Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Womens Health (Lond). 15, 1745506519864009 (2019).

CAS Google Scholar

Kanis, J.A., Cooper, C., Rizzoli, R., Reginster, J.Y., Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int. 30: 344 (2019).

Manson, J. E. et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: The womens health initiative randomized trials. JAMA 318, 927938 (2017).

Article Google Scholar

Langer, R. D. et al. Menopausal hormone therapy for primary prevention: Why the USPSTF is wrong. Climacteric 20, 402413 (2017).

Article CAS Google Scholar

Cummings, S. R. et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. JAMA 281, 21892197 (1999).

Article CAS Google Scholar

Garner, L. V. & Di Giulio, R. T. Glutathione transferase pi class 2 (GSTp2) protects against the cardiac deformities caused by exposure to PAHs but not PCB-126 in zebrafish embryos. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 155, 573579 (2012).

Article CAS Google Scholar

Frijhoff, J. et al. Clinical relevance of biomarkers of oxidative stress. Antioxid. Redox Signal. 23, 11441170 (2015).

Article CAS Google Scholar

Charitidi, K., Meltser, I. & Canlon, B. Estradiol treatment and hormonal fluctuations during the estrous cycle modulate the expression of estrogen receptors in the auditory system and the prepulse inhibition of acoustic startle response. Endocrinology 153, 44124421 (2012).

Article CAS Google Scholar

Yin, J. & Zhang, J. Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: From discovery to clinical application. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36, 927938 (2011).

CAS Google Scholar

Suzuki, H. & Sugiyama, Y. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin. Liver Dis. 18, 359376 (1998).

Article CAS Google Scholar

Adler, V. et al. Regulation of JNK signaling by GSTp. EMBO J. 18, 13211334 (1999).

Article CAS Google Scholar

Tew, K. D. & Townsend, D. M. Glutathione-s-transferases as determinants of cell survival and death. Antioxid. Redox Signal. 17, 17281737 (2012).

Article CAS Google Scholar

Zhang, J. et al. Pleiotropic functions of glutathione S-transferase P. Adv. Cancer Res. 122, 143175 (2014).

Article CAS Google Scholar

Cui, X. L. & Douglas, J. G. Arachidonic acid activates c-Jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc. Natl Acad. Sci. USA. 94, 37713776 (1997).

Article ADS CAS Google Scholar

Jimnez, L. A. et al. Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2. Am. J. Physiol. 273, L1029L1035 (1997).

Google Scholar

Kyriakis, J. M. et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156160 (1994).

Article ADS CAS Google Scholar

Yin, Z., Ivanov, V. N., Habelhah, H., Tew, K. & Ronai, Z. Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res. 60, 40534057 (2000).

CAS Google Scholar

Muthusami, S. et al. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin. Chim. Acta 360, 8186 (2005).

Article CAS Google Scholar

Steagall, R. J., Yao, F., Shaikh, S. R. & Abdel-Rahman, A. A. Estrogen receptor activation enhances its cell surface localization and improves myocardial redox status in ovariectomized rats. Life Sci. 182, 4149 (2017).

Article CAS Google Scholar

Lpez-Grueso, R. et al. Early, but not late onset estrogen replacement therapy prevents oxidative stress and metabolic alterations caused by ovariectomy. Antioxid. Redox Signal. 20, 236246 (2014).

Article Google Scholar

Topuoglu, A. et al. Effects of estrogens on oxidative protein damage in plasma and tissues in ovariectomised rats. Clin. Invest. Med. 32, E133E143 (2009).

Article Google Scholar

Bellanti, F. et al. Sex hormones modulate circulating antioxidant enzymes: Impact of estrogen therapy. Redox Biol. 1, 340346 (2013).

Article CAS Google Scholar

Koubaa-Ghorbel, F. et al. Salvia officinalis mitigates uterus and liver damages induced by an estrogen deficiency in ovariectomized rats. J. Food Biochem. 45, e13542 (2021).

Article CAS Google Scholar

Signorelli, S. S. et al. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53, 7782 (2006).

Article CAS Google Scholar

Richardson, T. E., Yu, A. E., Wen, Y., Yang, S. H. & Simpkins, J. W. Estrogen prevents oxidative damage to the mitochondria in friedreichs ataxia skin fibroblasts. PLoS ONE 7, e34600 (2012).

Article ADS CAS Google Scholar

Behl, C. & Manthey, D. Neuroprotective activities of estrogen: An update. J. Neurocytol. 29, 351358 (2000).

Article CAS Google Scholar

View original post here:
Effect of hormonal therapy on the otoconial changes caused by ... - Nature.com